
Preventing Hair Loss from Cancer Chemotherapy
Richard B. Schwab, MD. Associate Clinical Professor of Medicine,…

Mutational Oncology: The Basics
Vivian B. Douglas, PhD. Associate Knowledge Engineer, CollabRx…

The Most Relied Upon Journals in Precision Oncology
George Lundberg, MS, MD, ScD, MASCP, FCAP, Chief Medical Officer…

Length and Quality of Life in Cancer Patient Treatment
Professor Michael Baum, Professor Emeritus of Surgery & Visiting…

Canadian/American Cancer
Cynthia Martin, MA is a freelance/ghost writer (who tried to…

Conflict of Interest in Cancer Clinical Trials
Kevin B. Knopf, MD MPH, Medical Director, Cancer Commons
San…

Can Preclinical Data Guide Clinical Cancer Therapy?
Keith Flaherty, MD, Associate Professor of Medicine, Harvard…

Circadian Cancer Therapy
William Hrushesky, MD FACP, Founder and Chief Scientific Officer…

Generic Drugs vs. Biosimilar Biologics
Y. Tony Yang, ScD, LLM, MPH., Associate Professor, Department…

Driver and Passenger Mutations in Cancer Cell Genes
Michelle Turski, PhD, Senior Scientific Knowledge Engineer, CollabRx
Q:…

Patients and Physicians Should Share Decisions in Oncology
Brian Klepper, PhD, CEO and Founding Principal of Health Value…

Targeted Therapy for Waldenstrom’s Macroglobulinemia
Javier Munoz MD, FACP, Hematologist/Oncologist at Banner MD Anderson…

Using Patient Navigators to Improve Cancer Care
Valerie Fraser Cancer Research Advocate/Patient Navigator;
Inflammatory…

CollabRx and the 2016 Cancer Moonshot
George Lundberg, MS, MD, ScD, MASCP, FCAP, Chief Medical Officer…

Sun Exposure and Skin Cancer Risk
David Polsky, MD, PhD, Professor of Dermatology and Pathology;
Alfred…

Is there a Better Descriptive Name than Personalized Medicine?
Jerald P. Radich, MD, Director of the Molecular Oncology Lab…

Seeing the Forest for the Trees: How Cancer Evolution Affects Treatment
Lisandra E. West, PhD, Senior Scientific Knowledge Engineer,…

Multiple Sequential Biopsies now Standard of Care in NSCLC
Gregory Otterson, MD, Professor of Internal Medicine; Interim…

Use CUREUS to Build Rapid Learning Communities
John R. Adler, Jr., MD, CEO & Editor-in-Chief Cureus.com;
Dorothy…

Should All Potentially Lethal Tumors Be Sequenced?
Lisandra E. West, PhD, Senior Scientific Knowledge Engineer,…
